Growth Metrics

Lisata Therapeutics (LSTA) Current Assets (2016 - 2025)

Historic Current Assets for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $21.6 million.

  • Lisata Therapeutics' Current Assets fell 4275.97% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year decrease of 4275.97%. This contributed to the annual value of $34.6 million for FY2024, which is 3587.64% down from last year.
  • Latest data reveals that Lisata Therapeutics reported Current Assets of $21.6 million as of Q3 2025, which was down 4275.97% from $24.9 million recorded in Q2 2025.
  • In the past 5 years, Lisata Therapeutics' Current Assets registered a high of $65.3 million during Q1 2023, and its lowest value of $21.6 million during Q3 2025.
  • For the 3-year period, Lisata Therapeutics' Current Assets averaged around $43.2 million, with its median value being $42.0 million (2024).
  • As far as peak fluctuations go, Lisata Therapeutics' Current Assets tumbled by 2716.62% in 2024, and later crashed by 4275.97% in 2025.
  • Over the past 3 years, Lisata Therapeutics' Current Assets (Quarter) stood at $53.9 million in 2023, then crashed by 35.88% to $34.6 million in 2024, then tumbled by 37.6% to $21.6 million in 2025.
  • Its Current Assets stands at $21.6 million for Q3 2025, versus $24.9 million for Q2 2025 and $28.6 million for Q1 2025.